Dow Up 2.00% Nasdaq Up 1.66%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
1.52 Up 0.05(3.40%) Feb 12, 4:00PM EST
|After Hours : 1.52 Up 0.00 (0.02%) Feb 12, 5:07PM EST
Prev Close:1.47
Open:1.48
Bid:N/A
Ask:1.55 x 1500
1y Target Est:5.50
Beta:0.984398
Earnings Date:Feb 29 - Mar 4 (Est.)
Day's Range:1.41 - 1.52
52wk Range:1.30 - 5.12
Volume:1,378,983
Avg Vol (3m):2,791,150
Market Cap:368.68M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARNAUp 3.40%368.68M
OREXDown 0.61%238.53M
GSKUp 1.56%96.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.45
Quarterly EPS Est (Dec-15) :-0.13
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.16

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback